Apyx Medical

Apyx Medical FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Apyx Medical (APYX) as of Nov 1, 2026 is 81.30 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 79.99 % — a change of 1.64% (higher).

FCF Conversion

81.30 %

YoY

1.64%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Apyx Medical is 2025 81.30 % . FCF Conversion Rate (FCF/EBITDA) of Apyx Medical was 2024 79.99 % . It decreases by 1.64% higher compared to the previous year.

The Apyx Medical FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-33.39 USD
Jan 1, 2019
100.36 USD
Jan 1, 2020
139.94 USD
Jan 1, 2021
73.64 USD
Jan 1, 2022
91.83 USD
Jan 1, 2023
30.90 USD
Jan 1, 2024
79.99 USD
Jan 1, 2025
81.30 USD
The Apyx Medical FCF Conversion history
YEARFCF ConversionYoY
81.30 %+1.64%
79.99 %+158.89%
30.90 %-66.35%
91.83 %+24.71%
73.64 %-47.38%
139.94 %+39.44%
100.36 %-400.54%
-33.39 %-139.06%
85.50 %+8.14%
79.06 %-31.60%
115.59 %+1,807.90%
6.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apyx Medical Stock analysis

What does Apyx Medical do? Apyx Medical Corp is a US-American company specializing in the development and manufacturing of medical devices for medical aesthetics. The company is headquartered in Clearwater, Florida and has been listed on the Nasdaq stock exchange since 1997. However, the company was founded much earlier, in 1986, under the name Bovie Medical Corporation. Apyx Medical Corp's business model is focused on helping doctors and other medical professionals achieve better results for their patients. The company offers a wide range of medical aesthetic devices, which are divided into two main categories: devices for electrosurgery and devices for laser surgery. Electrosurgical devices use high frequencies to cut and coagulate tissue. These devices are primarily used for the removal of skin lesions, skin tightening, and the removal of wrinkles and excess tissue. Laser surgical devices, on the other hand, use laser beams to treat various skin problems, including the removal of wrinkles, pigmentation spots, and scars. Over the years, Apyx Medical Corp has become one of the leading companies in the field of medical aesthetics. The company is able to offer its customers a wide range of high-quality products that meet the highest standards of quality. The products of Apyx Medical Corp are used by medical professionals all over the world. The company also has a strong presence in the field of training and education for medical professionals. Apyx Medical Corp offers training and courses to ensure that doctors and other medical professionals can learn and apply the latest techniques and procedures in medical aesthetics. Apyx Medical Corp's products also include the J-Plasma and Renuvion systems. The Renuvion system is an advancement of the J-Plasma system and uses a high-frequency plasma arc to cut and coagulate tissue. The Renuvion system has a wide range of applications, ranging from fat removal to skin tightening. In recent years, Apyx Medical Corp has received a number of awards and recognitions. In 2019, the company was named one of America's best small companies by Forbes magazine. The company has also been included in Inc. Magazine's list of the 5000 fastest-growing companies. In the future, Apyx Medical Corp plans to further expand its product portfolio and strengthen its presence in the global market. The company is committed to providing its customers with the best products, training, and education in medical aesthetics and to remain a leading company in this field. In conclusion, Apyx Medical Corp is a leading company in the field of medical aesthetics, specializing in the development and manufacturing of medical devices. The company offers a wide range of high-quality products and training, and has become one of America's best small companies in recent years. Apyx Medical Corp has a promising future and is committed to providing its customers with the best products and services in the global market. Apyx Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apyx Medical stock

FCF Conversion Rate (FCF/EBITDA) of Apyx Medical is 81.30 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Apyx Medical changed from 79.99 % to 81.30 %, representing a 1.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Apyx Medical since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Apyx Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Apyx Medical

All Key Metrics — Apyx Medical